John Payne, President and Chief Executive Officer of Zivo Bioscience Inc (ZIVO), purchased 6,343 shares of the company on October 16, 2024, according to a recen
On August 22, 2024, Christopher Maggiore, serving as Director and 10% Owner, purchased 31,336 shares of Zivo Bioscience Inc (ZIVO) as reported in a recent SEC F
NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common shares of Sono Group N.V. Sono Group N.V.'s securities were suspended on July 21, 2023, and have not
NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common shares of Sono Group N.V. Sono Group...
Zivo Bioscience, Inc. , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces it has...